Fellowships, Grants, & Awards by unknown
Metals in Medicine
The objective of this program announcement (PA) is
to encourage research that bridges the areas of inor-
ganic chemistry and medicine in continuation of PA-
01-071. The National Institute of General Medical
Science (NIGMS) is joined in this announcement by
the NIEHS and the NIH Office of Dietary
Supplements (ODS). 
The mechanisms by which organisms control
transition metal ions and the roles of these metals in
cellular regulation and signaling in health and disease
are of principal interest. The interactions of synthetic
inorganic complexes with living systems and their
components are an additional area of interest. These
areas are linked by the need to involve researchers hav-
ing a deep understanding of inorganic chemistry in
medically relevant research. Much of the work is
expected to involve collaborations including chemists,
biologists, and medical researchers. The results will be
relevant to understanding the mechanisms of metal
handling by biological systems and the basic cellular
roles underlying the nutritional requirement for essen-
tial metals. It is expected that this research will also
contribute to the identiﬁcation of new targets for drug
discovery, diagnostics, and future therapeutic
approaches involving metal complexes, although drug
development, per se, is not a focus of the program.
A higher-order problem presents itself in under-
standing how the genome-encoded components and
the other molecules are constituted in networks of
interacting molecules with particular distributions in
time and space. Advances in imaging techniques and
analytic methods are beginning to yield copious quan-
titative and spatial data on speciﬁc molecules in biolog-
ical systems. Knowledge of the network and changes in
its components over time, and the local rules by which
the individual components distribute material and
information, will substantially advance our knowledge.
Studies of metalloenzyme structure and func-
tion, mechanisms of action, and inhibition are cur-
rently well supported and produce results that are
utilized in the design of new diagnostic and thera-
peutic products. Additional stimulation of this area
is not needed. In contrast, work in other areas of
bioinorganic chemistry lags behind its potential
application to human health. These areas include 1)
mechanisms of metal metabolism as well as the roles
of metals in regulation of cell function and cell–cell
interaction, and 2) basic research toward diagnostic
and therapeutic applications of metal complexes and
of metal chelators and toward exploiting the unique
properties of metals for therapeutic applications. The
emphasis of this announcement is on the ions, com-
plexes, and organometallic compounds of the transi-
tion metals known as lanthanides and actinides,
post-transition metals, and metalloid elements.
Metal Metabolism and Regulation. Metal metabo-
lism is emerging as an exciting area of cell biology and
a potential area for therapeutic intervention. Normal
metal metabolism appears to maintain free metal ion
concentrations at a very low level and to deliver metals
very selectively to their sites of action, while maintain-
ing tight control over their reactivity. Aberrant metal
metabolism contributes to pathological conditions
such as Menkes’ disease, Wilson’s disease, and
hemochromatosis. Intercepting normal metalation
reactions may be a way to control metalloprotein activ-
ity. Metals may also be associated with the pathology
of protein aggregates such as those formed by prions
and in Alzheimer’s disease. Metals have also emerged
as important sensors and transducers of information
with roles in regulation and neurotransmission.
Areas of interest include 1) improved metal ion
sensors to study cellular metal ion concentrations and
localization; 2) reagents suitable to manipulate those
concentrations; 3) identiﬁcation and characterization
of the macromolecular players and vesicular compart-
ments involved in metal ion homeostasis and metal
trafﬁcking; 4) elucidation of the roles of metals in cell
regulation, signal transduction, and cell–cell signaling;
5) identification and understanding of mRNAs and
metal-, oxygen-, and redox-responsive transcriptional
and translational regulators, and their potential as ther-
apeutic targets; 6) elucidation of the mechanistic roles
of essential trace elements for which metabolic func-
tions are not yet clearly established; 7) analytical tools
that accurately monitor biologically important pools,
storage pools, and the chemical speciation of metals; 8)
biomarkers of exposure and mechanisms of metal toxi-
city; 9) biomarkers for variable susceptibility to metal
toxicity in the human population; and 10) chelation
chemistry that can serve as the foundation for therapies
to ameliorate aberrant metal accumulations and the
effects of toxic exposures.
Interactions of Metal Complexes with Living
Systems. The therapeutic application of metal com-
plexes is an underdeveloped area of research. Basic
principles to guide the development of metallophar-
maceuticals are lacking. Metal-containing agents
may offer unique therapeutic opportunities.
However, significant obstacles, including potential
metal accumulations and toxicities, require further
research before the promise of medicinal inorganic
chemistry can be realized.
Metal complexes may be useful as research probes
of biological function, as intermediary lead com-
pounds in the development of non–metal-containing
therapeutics, and as potential diagnostic and therapeu-
tic agents. Opportunities exist to exploit the unique
properties of metal complexes, (e.g., hydrolytic and
redox activity, Lewis acidity, electrophilicity, valency,
geometry, magnetic, spectroscopic, radiochemical
properties) to measure and/or alter cellular functions.
The actions of these compounds may provide insights
that are different from those that can be achieved
through other chemical, biochemical, or genetic
manipulations. Similarly, the actions of metal com-
plexes in whole living organisms are expected to differ
in general from the actions of non–metal-containing
agents and may offer unique research, diagnostic, or
therapeutic opportunities. Principles are needed for the
design of safe metal-containing therapeutics. 
Another goal of this program is to utilize the
power of inorganic chemistry to provide new knowl-
edge of and new approaches for intervention in bio-
logical systems. Still another goal is to improve
understanding of the reactions of metal complexes in
living systems to improve the specificity of these
interactions and gain control over the potential toxi-
city of synthetic metal complexes. The long-term
goal is to establish the basic principles of an inor-
ganic medicinal chemistry that will allow for rational
design and screening of potential metallopharmaceu-
ticals in the future. 
Areas of interest include 1) reactions of metal
complexes with cellular constituents (e.g., DNA,
RNA, proteins, lipids, carbohydrates, redox sub-
strates, signaling molecules); 2) reactions of metal
complexes within the cellular milieu and in vivo; 3)
uptake of metal complexes into cells and delivery to
specific cellular compartments; 4) interactions of
metal complexes with specific enzymes and recep-
tors; 5) mechanisms by which synthetic metal com-
plexes recruit cell cycle, signal transduction, and
other metabolic pathways to alter cell functions; and
6) structure–activity relationships for ligand design
to control metal complex activity and stability in
vitro and in vivo.
The NIH Metals in Medicine meeting report
includes a list of specific research opportunities and
challenges. This list is intended to be illustrative, not
exhaustive. Investigator-initiated ideas are welcome on
any subject that will contribute to the objectives listed
in this PA.
Research encouraged by this announcement may
utilize any appropriate experimental organisms or
model systems. For some problems, interesting discov-
eries may be found in microorganisms from unusual
environments and atypical experimental organisms.
For other problems, yeast, common invertebrate and
vertebrate model organisms, and human cell/tissue cul-
tures may be appropriate. Investigators considering
human clinical trials are strongly encouraged to con-
tact the program staff.
This funding opportunity will use the regular
research (R01), exploratory research (R21), and pro-
gram project (P01) award mechanisms. For a
description of the R21 grant mechanism see
http://grants.nih.gov/grants/funding/r21.htm. For
descriptions of the P01 grant mechanism see
http://www.nigms.nih.gov/funding/grntmech.
html#b (NIGMS) and http://www.niehs.nih.gov/
dert/programs/p01.htm (NIEHS).
This funding opportunity uses just-in-time con-
cepts. It also uses the modular as well as the nonmodu-
lar budget formats (see http://grants.nih.gov/grants/
funding/modular/modular.htm). Specifically, if you
are submitting an application with direct costs in each
year of $250,000 or less, use the modular budget for-
mat described in the PHS 398 application instruc-
tions, available at http://grants1.nih.gov/grants/
funding/phs398/phs398.html in an interactive format.
Otherwise, follow the instructions for nonmodular
research grant applications. For further assistance, con-
tact GrantsInfo at 301-435-0714 (telecommunications
for the hearing impaired: TTY 301-451-0088) or by e-
mail: GrantsInfo@nih.gov. 
Applications must be prepared using the PHS 398
application instructions and forms (rev. 5/2001).
Applications must have a Dun & Bradstreet (D&B)
Data Universal Numbering System number as the uni-
versal identifier when applying for federal grants or
cooperative agreements. This number can be obtained
by calling 1-866-705-5711 or online at http://www.
dnb.com/us/. The D&B number should be entered on
line 11 of the face page of the PHS 398 form.
Applications must be submitted on or before the
receipt date described at http://grants.nih.gov/grants/
funding/submissionschedule.htm. The complete ver-
sion of this PA is available at http://grants.nih.gov/
grants/guide/pa-ﬁles/PA-05-001.html.
Contact: Peter C. Preusch, Division of Pharma-
cology, Physiology, and Biological Chemistry,
NIGMS, Bldg 45, Rm 2AS.43C, MSC 6200,
Bethesda, MD 20892-6200 USA, 301-594-5938, fax:
301-480-2802, e-mail: preuschp@nigms.nih.gov;
Claudia Thompson, NIEHS, DERT/OPD/CEMBB,
MD EC-21, PO Box 12233, Research Triangle Park,
NC 27709 USA, 919-541-4638, fax: 919-541-4606,
e-mail: thompso1@niehs.nih.gov; Becky Costello,
ODS, NIH, Bldg 31, Rm 1B25, MSC 2086,
Bethesda, MD 20892-2086 USA, 301-435-2920, fax:
301-480-1845, e-mail: costellb@od.nih.gov.
Reference: PA No. PA-05-001
NIGMS National Centers for Systems Biology
The National Institute of General Medical Sciences
(NIGMS) currently supports the analysis of complex
biological systems through investigator-initiated
research project grants. The resources needed to con-
duct the multifaceted, multidisciplinary projects that
may be required to achieve significant advances in
these complex areas may be beyond the scope of the
typical R01 or P01 grant. Therefore, this request for
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cants to assemble large teams of investigators from
diverse disciplines that may not be possible with other
funding mechanisms.
The biomedical sciences have undergone a funda-
mental shift in the conceptual and technical
approaches that can be applied to certain problems of
profound importance. These problems center on
understanding the behavior of biological systems whose
function is the product of spatial and temporal order-
ing of myriad interacting components. Modeling
approaches are being used to understand the orderly
development of biological pattern in organisms such as
Drosophila and Caenorhabditis elegans, and at the clini-
cal level, new approaches are being explored to under-
stand the integrated activity of tissues and organs. 
Part of the impetus for systems-scale approaches
rests on advances in acquiring data of the necessary
quality and quantity to permit computational mod-
eling. Among the most striking examples are the
availability of complete DNA sequences for hun-
dreds of organisms, including humans, and the avail-
ability of high-throughput instrumentation for
analyses of gene function such as gene expression
microarrays and proteomics technologies. These
advances have made it feasible to generate a truly
comprehensive parts list for any organism and to
track changes over time. Ultimately, it should be
possible to enumerate all the informational units of
the genomes (protein coding genes, non–protein
coding genes, regulatory regions), their processed
forms, and their dynamic presence in cells. 
Rapid advances in large-scale data collection and
analysis have given scientists a global yet detailed view
of cellular processes, instead of focusing on individual
molecules or a small number of interacting molecules.
Unprecedented opportunities have emerged that may
open the door to uncover hidden rules governing the
ensemble of biomolecules working concertedly to per-
form certain functions in the cell. In the meantime,
substantial challenges in information integration, inter-
pretation, and representation have arisen. In order to
move beyond the phase of cataloguing the parts list
and truly transform data into knowledge, and knowl-
edge into principles, iterative cycles of data collection
and model generation and validation will be necessary. 
A higher-order problem presents itself in under-
standing how the genome-encoded components and
the other molecules (metabolites, ions, water, etc.) are
constituted in networks of interacting molecules with
particular distributions in time and space. Advances in
imaging techniques and analytic methods are begin-
ning to yield copious quantitative and spatial data on
speciﬁc molecules in biological systems. Knowledge of
the network and changes in its components over time,
and the local rules by which the individual components
distribute material and information, will substantially
advance our knowledge.
At the organism level, phenotype must take into
account the relationships and interactions of biological
and environmental variables. Basic biological sys-
tems—including gene sequences, structures, and path-
ways that direct metabolism and development—vary
within individuals, among individuals, among popula-
tions, and among species. Advances in complex sys-
tems-level understanding must ultimately include
models that account for these variations. 
Medical, biotechnological, and other uses of
biological information increasingly depend on our
ability to understand the principles and dynamics
that explain the behavior of the system as a whole.
Whether the goal is to understand the consequences
of disease or injury, identify particular molecular tar-
gets for drug interventions, or modify the metabo-
lism of microorganisms to produce medicines, the
challenge is predictability. Predicting how the system
of interest will respond to an intervention is a com-
putational problem. For biological systems, this chal-
lenge is daunting. 
Parallel to scientiﬁc challenges are organizational
and educational challenges. At the institutional level,
building cohesive multidisciplinary research teams by
integrating expertise across traditional disciplinary
boundaries is not a simple undertaking. Beyond insti-
tutions, excessive overlap and redundancy in project
selection and tool development exists in the research
communities that could be reduced by promoting
communications, collaborations, and technology and
data sharing. The emergence of new science demands
an adequate workforce of new scientists. Training for
the future leaders of systems biology research who are
knowledgeable and skilled in both experimental and
computational subjects is timely. Good mechanisms
and plans to address these challenges are significant
tasks of the centers.
High priority will be given to projects that inte-
grate multi-investigator, multidisciplinary approaches
with a high degree of interplay between computational
and experimental approaches. Innovation is critical for
both research project design and infrastructure design
with a mission of serving communities beyond the par-
ticipating investigators, institutions, and collaborators.
A variety of organizational models are possible; it is not
the intent of this RFA to prescribe any particular one.
The NIGMS awarded two centers under this pro-
gram in 2002 (http://www.nigms.nih.gov/news/releases/
complex_centers.html), two centers in 2003 (http://
www.nigms.nih.gov/news/releases/complex_
centers-2003.html), and one center in 2004 (http://www.
nigms.nih.gov/news/releases/quantitative_bio_center.
html). Potential applicants should become familiar
with the research focuses of the existing centers.
Research conducted by the future centers should com-
plement and enhance projects already funded.
Some groups interested in the subject of this RFA
might ﬁnd the P01 mechanism more suited to the scale
of their efforts; they should consult the prior
announcement at http://grants.nih.gov/grants/guide/
pa-ﬁles/PA-98-077.html.
The NIGMS intends to support systems biology
research for the areas that are central to its mission of
supporting basic biomedical research, and that focus
on developing new computational approaches to bio-
medical complexity. Research areas that historically
have been computationally based (e.g., molecular
structure and modeling) are excluded as a focus of this
center program. Research focusing on disease
processes and their speciﬁc organ systems is not eligi-
ble. NIGMS mission areas include, but are not lim-
ited to, the following: 1) signaling networks and the
regulatory dynamics of cellular processes such as cell
cycle control, transient complex formation, organelle
biogenesis, and intercellular communications; 2)
supramolecular machines, such as the replisome, spli-
ceosome, and molecular motor assemblies in cell divi-
sion and motility; 3) pattern formation and
developmental processes in model systems (e.g.,
Drosophila, C. elegans, etc.); 4) metabolic networks
and the control of the flux of substrates, intermedi-
ates, and products in cell physiology; 5) organ system
networks involved in multiorgan failure in shock,
trauma, and burn injury; and 6) genetic architecture
of biological complexity related to inherited variation
and environmental ﬂuctuations.
The NIGMS National Centers for Systems
Biology will be expected to provide national leader-
ship in systems biology research and training. To do
so, they will be expected to support training and out-
reach activities that will ensure the ﬂow of informa-
tion and expertise both into and out of the centers.
Centers should have plans to bring the most advanced
technologies developed at other laboratories to the
centers and to disseminate expertise and knowledge to
a wider community through collaborations, visiting
investigatorships, fellowships, center websites, work-
shops, symposia, summer courses/internships, and/or
other means. To maximize the impact, centers should
conduct training at multiple levels appropriate to their
institutions. Incorporation of developmental research
projects led by junior and new investigators into the
center research and development plans is strongly
encouraged. Over a period of time, centers should
evolve into integrated research, training, and knowl-
edge exchange headquarters of scientiﬁc communities
that will be the engines for coordinated scientiﬁc dis-
coveries. The centers should also have plans for out-
reach to undergraduate institutions, including
minority-serving institutions. Information on relevant
minority-serving institutions may be obtained by con-
sultation with staff of the NIGMS Division of
Minority Opportunities in Research (http://www.
nigms.nih.gov/about_nigms/more.html).
In addition to research and training contributions,
successful centers will provide their home institutions
with the means to implement organizational and pro-
fessional changes that will make systems biology
research an attractive career option for both established
and entry-level investigators.
This funding opportunity will use the NIH P50
Research Center Grant award mechanism. As an
applicant, you will be solely responsible for planning,
directing, and executing the proposed project. This
RFA is a one-time solicitation and may be rean-
nounced in the future. The earliest expected award
date is in December 2005. Applications that were
submitted in response to previous RFAs of this pro-
gram but unfunded may be revised and resubmitted
for this RFA.
The NIGMS intends to commit up to $7 million
in ﬁscal year 2006 to fund one to three new P50 center
grants in response to this RFA. An applicant may
request a project period of up to ﬁve years and a budget
for direct costs of up to $2 million per year, exclusive
of subproject fiscal and administrative costs (see
http://grants.nih.gov/grants/guide/notice-files/
NOT-OD-04-040.html).
The PHS 398 application instructions are avail-
able at http://grants.nih.gov/grants/funding/
phs398/phs398.html in an interactive format. For fur-
ther assistance, contact GrantsInfo by calling 301-435-
0714 or e-mailing GrantsInfo@nih.gov.
Applications must be prepared using the PHS 398
application instructions and forms (rev. 5/2001).
Applications must have a Dun & Bradstreet (D&B)
Data Universal Numbering System number as the uni-
versal identifier when applying for federal grants or
cooperative agreements. This number can be obtained
by calling 1-866-705-5711 or online at http://www.
dnb.com/us/. The D&B number should be entered on
line 11 of the face page of the PHS 398 form. 
Letters of intent must be received by 25 January
2005, with 25 February 2005 the deadline for applica-
tions. The complete version of this announcement is
available online at http://grants.nih.gov/grants/
guide/rfa-ﬁles/RFA-GM-05-010.html#PartI. 
Contact: James J. Anderson, Center for Bioinfor-
matics and Computational Biology, NIGMS, 45
Center Dr, Rm 2As.25A, MSC 6200, Bethesda, MD
20892-6200 USA, 301-594-0943, fax: 301-480-
2228, e-mail: andersoj@nigms.nih.gov; Jiayin (Jerry)
Li, Center for Bioinformatics and Computational
Biology, NIGMS, 45 Center Dr, Rm 2As.19F, MSC
6200, Bethesda, MD 20892-6200 USA, 301-594-
0682, fax: 301-480-2004, e-mail: lij@nigms.nih.gov.
Reference: RFA No. RFA-GM-03-009
Fellowships, Grants, & Awards
Environmental Health Perspectives • VOLUME 113 | NUMBER 1 | January 2005 A 55